1. Home
  2. IPHA vs EM Comparison

IPHA vs EM Comparison

Compare IPHA & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • EM
  • Stock Information
  • Founded
  • IPHA 1999
  • EM 2017
  • Country
  • IPHA France
  • EM China
  • Employees
  • IPHA N/A
  • EM N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • EM Other Consumer Services
  • Sector
  • IPHA Health Care
  • EM Consumer Discretionary
  • Exchange
  • IPHA Nasdaq
  • EM Nasdaq
  • Market Cap
  • IPHA 160.1M
  • EM 289.1M
  • IPO Year
  • IPHA 2019
  • EM 2021
  • Fundamental
  • Price
  • IPHA N/A
  • EM $1.15
  • Analyst Decision
  • IPHA Strong Buy
  • EM Hold
  • Analyst Count
  • IPHA 1
  • EM 1
  • Target Price
  • IPHA $11.00
  • EM $1.25
  • AVG Volume (30 Days)
  • IPHA 11.7K
  • EM 84.9K
  • Earning Date
  • IPHA 03-27-2025
  • EM 08-21-2025
  • Dividend Yield
  • IPHA N/A
  • EM N/A
  • EPS Growth
  • IPHA N/A
  • EM N/A
  • EPS
  • IPHA N/A
  • EM N/A
  • Revenue
  • IPHA $20,831,349.00
  • EM $259,541,587.00
  • Revenue This Year
  • IPHA $209.83
  • EM $3.30
  • Revenue Next Year
  • IPHA $83.15
  • EM $5.26
  • P/E Ratio
  • IPHA N/A
  • EM N/A
  • Revenue Growth
  • IPHA N/A
  • EM N/A
  • 52 Week Low
  • IPHA $1.29
  • EM $0.50
  • 52 Week High
  • IPHA $3.51
  • EM $1.17
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 39.24
  • EM 60.50
  • Support Level
  • IPHA $1.71
  • EM $1.12
  • Resistance Level
  • IPHA $1.90
  • EM $1.17
  • Average True Range (ATR)
  • IPHA 0.09
  • EM 0.03
  • MACD
  • IPHA -0.00
  • EM 0.00
  • Stochastic Oscillator
  • IPHA 40.74
  • EM 64.71

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About EM Smart Share Global Limited

Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.

Share on Social Networks: